Literature DB >> 20638686

The number of lymph nodes examined debate in colon cancer: how much is enough?

Stephanie R Downing1, Kerry-Ann Cadogan, Gezzer Ortega, Zenab Jaji, Oluwaseyi B Bolorunduro, Tolulope A Oyetunji, David C Chang, Debra H Ford, Wayne A I Frederick.   

Abstract

BACKGROUND: Much debate exists over the significance of the number of lymph nodes (LN) examined after colon resection.
MATERIALS AND METHODS: The Surveillance, Epidemiology and End Results (SEER) database was queried for patients who presented with colonic adenocarcinoma. Multiple Cox proportional hazard regressions were run using successive LN cut-offs (6-26), first controlling for and then stratifying by T-stage. This was repeated in subsets of patients delineated by LN status. Additional variables controlled for in every regression were age, gender, ethnicity, marital status, number of positive LN, grade, metastases, and extent of surgery. After each regression, a Harrell's C statistic and an Akaike's information criterion (AIC) were performed to test the predictive capacity and fit of the model, respectively.
RESULTS: 128,071 patients met selection criteria. The highest Harrell's C statistics among all patients were the cutoffs at 14 LN and 15 LN. Between those, the AIC shows that the cutoff at 15 LN fit the data more closely than the 14 LN cutoff. The models with the best predictive ability and best fit by T-stage were T1, 14 LN; T2, 10 LN; T3, 10 LN; T4, 12 LN.
CONCLUSIONS: Using a population-based dataset, we show the optimal number of LN examined is dependent upon the patient's tumor stage. Across all T-stages, the highest optimal number of LN resected was 15. Since it is possible to estimate but not perfectly predict the stage of a patient's tumor preoperatively, we believe the recommendation should be based on the most conservative measure.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20638686     DOI: 10.1016/j.jss.2010.03.017

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Evaluation of lymph nodes in patients with colon cancer undergoing colon resection: a population-based study.

Authors:  Yun-Jau Chang; Yao-Jen Chang; Li-Ju Chen; Kuo-Piao Chung; Mei-Shu Lai
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

2.  Adjuvant treatment of early colon cancer with micrometastases: results of a national survey.

Authors:  Scott S Short; Alexander Stojadinovic; Aviram Nissan; Zev Wainberg; Deepti Dhall; Kathy Yao; Anton Bilchik
Journal:  J Surg Oncol       Date:  2012-02-03       Impact factor: 3.454

3.  Extended lymphadenectomy in colon cancer is debatable.

Authors:  Jamie Murphy; Tonia Young-Fadok
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

4.  Deaths of colon neuroendocrine tumors are associated with increasing metastatic lymph nodes and lymph node ratio.

Authors:  Changchun Xiao; Baorong Song; Peipei Yi; Yangyang Xie; Biqing Li; Peng Lian; Shaoqing Ding; Yuanming Lu
Journal:  J Gastrointest Oncol       Date:  2020-12

5.  Which is the most suitable classification for colorectal cancer, log odds, the number or the ratio of positive lymph nodes?

Authors:  Yong-Xi Song; Peng Gao; Zhen-Ning Wang; Lin-Lin Tong; Ying-Ying Xu; Zhe Sun; Cheng-Zhong Xing; Hui-Mian Xu
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

6.  Integrated ratio of metastatic to examined lymph nodes and number of metastatic lymph nodes into the AJCC staging system for colon cancer.

Authors:  Peng Gao; Yong-xi Song; Zhen-ning Wang; Ying-ying Xu; Lin-lin Tong; Jin-liang Zhu; Qing-chao Tang; Hui-mian Xu
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.